RADIOPHARM THERANOSTICS LTD Share Price Today: Live Updates & Key Insights
RADIOPHARM THERANOSTICS LTD share price today is $4.91, up 1.59%. The stock opened at $4.46 against the previous close of $4.72, with an intraday high of $4.94 and low of $4.45.
RADIOPHARM THERANOSTICS LTD Share Price Chart
RADIOPHARM THERANOSTICS LTD
RADIOPHARM THERANOSTICS LTD Share Price Performance
RADIOPHARM THERANOSTICS LTD Institutional Holdings
RADIOPHARM THERANOSTICS LTD Market Status
RADIOPHARM THERANOSTICS LTD Fundamentals
Market Cap 37.80 M
PB Ratio 1.2219
PE Ratio 0.0
Enterprise Value 12.78 M
Total Assets 86.48 M
Volume 43203
RADIOPHARM THERANOSTICS LTD Company Financials
About RADIOPHARM THERANOSTICS LTD & investment objective
Company Information Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia.
Organisation Biotechnology
Employees 14
Industry Biotechnology
CEO Mr. Riccardo Canevari
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
RADIOPHARM THERANOSTICS LTD FAQs
What is the share price of RADIOPHARM THERANOSTICS LTD today?
The current share price of RADIOPHARM THERANOSTICS LTD is $4.91.
Can I buy RADIOPHARM THERANOSTICS LTD shares in India?
Yes, Indian investors can buy RADIOPHARM THERANOSTICS LTD shares by opening an international trading and demat account with Motilal Oswal.
How to buy RADIOPHARM THERANOSTICS LTD shares in India?
You can easily invest in RADIOPHARM THERANOSTICS LTD shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy RADIOPHARM THERANOSTICS LTD shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of RADIOPHARM THERANOSTICS LTD.
Can I buy fractional shares of RADIOPHARM THERANOSTICS LTD?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of RADIOPHARM THERANOSTICS LTD?
RADIOPHARM THERANOSTICS LTD has a market cap of $37.80 M.
In which sector does RADIOPHARM THERANOSTICS LTD belong?
RADIOPHARM THERANOSTICS LTD operates in the Biotechnology sector.
What documents are required to invest in RADIOPHARM THERANOSTICS LTD stocks?
To invest, you typically need:
What is the PE and PB ratio of RADIOPHARM THERANOSTICS LTD?
The PE ratio of RADIOPHARM THERANOSTICS LTD is N/A and the PB ratio is 1.22.